Collegium Pharmaceutical (COLL) Other Working Capital Changes (2014 - 2026)

Collegium Pharmaceutical's Other Working Capital Changes history runs 13 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 140.23% year-over-year to -$4.1 million in Q1 2026; TTM through Mar 2026 was -$6.4 million, a 126.63% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, down 43.37% from the prior year.
• Other Working Capital Changes steadied at -$167000.0 in Q1 2026 per COLL's latest filing, from -$167000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $11.5 million in Q2 2024 and bottomed at -$21.3 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is $432000.0 (2022), against an average of $1.2 million.
• Biggest YoY gain for Other Working Capital Changes was 5703.39% in 2025; the steepest drop was 5016.36% in 2025.
• Year by year, Other Working Capital Changes stood at -$167000.0 in 2025, then changed by 0.0% to -$167000.0 in 2026.
• Per Business Quant, the three latest COLL Other Working Capital Changes figures stand at -$167000.0 (Q1 2026), -$167000.0 (Q4 2025), and -$676000.0 (Q1 2019).